Following the discovery that Tspan6 enhances the chemoattractive potential of breast cancer cells for B lymphocytes in an EV-dependent manner, it was shown that this effect relied on the function of liver X receptors, which are nuclear receptors for oxysterols, in B cells. Here, TSPAN6 is linked to breast carcinoma.